Volume | 27,522 |
|
|||||
News | - | ||||||
Day High | 0.007 | Low High |
|||||
Day Low | 0.00665 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
GB Sciences Inc (PK) | GBLX | OTCMarkets | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
0.007 | 0.00665 | 0.007 | 0.00665 | 0.00661 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
5 | 27,522 | US$ 0.006723 | US$ 185 | - | 0.005 - 0.016 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
14:00:30 | 5 | US$ 0.00683 | USD |
GB Sciences Inc (PK) Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
US$ 2.54M | 381.87M | 291.03M | - | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
GB Sciences (PK) News
Date | Time | Source | News Article |
---|---|---|---|
2/12/2024 | 15:39 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
11/20/2023 | 16:07 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
10/10/2023 | 09:00 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] |
9/08/2023 | 15:15 | Edgar (US Regulatory) | Form 8-K - Current report |
8/14/2023 | 13:31 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
8/02/2023 | 15:18 | Edgar (US Regulatory) | Form D - Notice of Exempt Offering of Securities |
7/14/2023 | 15:12 | Edgar (US Regulatory) | Form 10-K - Annual report [Section 13 and 15(d), not S-K.. |
6/30/2023 | 07:00 | Edgar (US Regulatory) | Form NT 10-K - Notification of inability to timely file Form.. |
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical GBLX Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.0062 | 0.0082 | 0.0062 | 0.007094 | 92,975 | 0.00045 | 7.26% |
1 Month | 0.0066 | 0.0082 | 0.005 | 0.0065919 | 95,514 | 0.00005 | 0.76% |
3 Months | 0.007 | 0.01 | 0.005 | 0.0063682 | 117,081 | -0.00035 | -5.00% |
6 Months | 0.0069 | 0.01 | 0.005 | 0.0063142 | 151,188 | -0.00025 | -3.62% |
1 Year | 0.016 | 0.016 | 0.005 | 0.0082794 | 152,619 | -0.00935 | -58.44% |
3 Years | 0.055 | 0.0694 | 0.005 | 0.0270238 | 206,595 | -0.04835 | -87.91% |
5 Years | 0.158 | 0.165 | 0.005 | 0.0514479 | 339,270 | -0.15135 | -95.79% |
GB Sciences (PK) Description
GB Sciences, Inc. is a plant-inspired, biopharmaceutical research and development company creating patented, disease-targeted formulations of cannabis- and other plant-inspired therapeutic mixtures for the prescription drug market. |